Abstract
We are now entering a period when the process of unraveling the puzzles of ‘Parkinson's Disease’ has generated a mass of information that does not fit into our traditional concepts. Having split off ‘Progressive Supranuclear Palsy’ and ‘Multiple System Atrophy’, we are faced with the dilemma of what to do with the various forms of Parkinsonism caused by a number of different mutations, and how to interpret pathological heterogeneity. Faced with these new questions, it is time to reconsider how ‘Parkinson's Disease’ is to be defined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
